Antares Pharma, Inc. (ATRS)

Other Income/Expenses (Net)

-$2.14M

TTM · Period ending: · USD

ATRS logo

ATRS Other Income/Expenses (Net)

Latest reported-$2.14M
ATRS TTM Other Income/Expenses (Net) ($0.00 → -$2.14M)
High-resolution chart · PNG

ATRS other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
-2,142,000
-2,976,000
-3,968,000
-4,078,000
-3,721,000
-3,698,000
-3,578,000
-3,677,000
-3,447,000
-3,019,000
-2,801,000
-2,425,000
-2,397,000
-2,414,000
-1,454,874
-1,384,585
-895,926
-292,000
-777,783
-255,610
-144,484
-122,344
97,812
111,876
75,910
-21,867
-69,116
-111,479
-72,870
-13,420
6,393
28,453
62,439
43,541
64,422
40,174
-3,775
24,049
-55,170
-72,903
-14,070
-5,838
-40,835
13,992
-36,088
-91,057
65,517
31,114
5,378
-167,515
-226,991
-232,763
-188,979
-23,870
-52,330
-36,867
-67,785
-33,030
-141,388
-171,943
-151,465
-173,121
-42,153
-23,606
-27,336
-3,086
15,089
23,627
17,921
25,018
-139,449
-20,793,729
-22,473,216
-23,235,355
-22,462,704
-3,703,728
-2,069,789
-1,307,549
-1,939,104
-34,763
69,975
73,464
68,684
65,760
16,180
0
0
0
0
0
0
100,000
200,000
300,000
300,000
300,000
300,000
200,000
200,000
100,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.